Published on 21/11/2025

Safety Reconciliation with EDC/Source in Practice: Step-by-Step Guide for Sponsors and CROs

Effective safety reconciliation is a critical aspect of clinical trials, particularly when it comes to managing adverse events (AEs) and serious adverse events (SAEs). For clinical research organization companies, ensuring accurate, efficient reconciliation between electronic data capture (EDC) systems and source documents is vital. This comprehensive guide aims to provide a structured approach to safety reconciliation, designed for clinical operations, regulatory affairs, and medical affairs professionals involved in trial management in the US, UK, and EU.

Understanding Safety Reconciliation

Safety reconciliation is the process that ensures all adverse events documented in source data are correctly recorded in the EDC system. The primary aim is to maintain data integrity and compliance with regulatory requirements from entities such as the FDA, EMA, and MHRA. The need for accurate reconciliation cannot be overstated, as discrepancies can lead to compromised data quality, regulatory non-compliance, and ultimately adversely affect patient safety.

In the context of regulatory compliance, safety reconciliation includes comparing the safety data collected from various sources, such as clinical sites, laboratory reports, and patient diaries, against EDC entries. Often, clinical trial protocols involve numerous data sources that must be managed simultaneously. Thus, understanding how to conduct thorough reconciliation is essential for clinical trial sponsors and CROs.

Key Components of Safety Reconciliation

• Adverse Events (AEs): Any unfavorable medical occurrence in a patient during a clinical trial.
• Serious Adverse Events (SAEs): AEs that result in death, are life-threatening, require hospitalization, or result in significant disability.
• Source Data: Original records or certified copies collected during a clinical trial (e.g., case report forms, lab results).

The Importance of Compliance in Safety Reconciliation

Sponsors and CROs must prioritize compliance with ICH-GCP guidelines while conducting safety reconciliation. Non-compliance can result in severe consequences, including trial delays, data invalidation, and a detrimental impact on participant safety. Moreover, regulatory bodies require comprehensive safety data for the evaluation of new drugs, devices, or therapies, particularly in sensitive studies such as biosimilar clinical trials or til therapy clinical trials.

Integrating compliance checks into the reconciliation process helps streamline review and ensures that all data entered into the EDC aligns with source documentation. The enhanced focus on data integrity not only safeguards the clinical trials’ outcomes but also supports timely and accurate reporting to regulatory bodies.

Common Regulatory Guidelines

Understanding relevant regulations is crucial. Some key guidelines include:

• ICH-GCP: Provides an international ethical and scientific quality standard for designing, conducting, recording, and reporting trials.
• FDA Regulations: Detailed in Title 21 of the Code of Federal Regulations (CFR), these govern the obligations of sponsors in ensuring data integrity.
• EMA Guidelines: Similar to FDA regulations, with an emphasis on protecting patients and ensuring that clinical trials are conducted adhering to high quality standards.

Step-by-Step Guide to Safety Reconciliation

Step 1: Prepare for Reconciliation

The first step involves gathering the necessary documents and preparing the required tools for the reconciliation process. Some of the vital aspects include:

• Organizing Source Documents: Collect all relevant source documents associated with AEs and SAEs.
• Accessing EDC System: Ensure that you have access to the EDC system where data has been recorded.
• Utilizing Query Management Tools: These tools facilitate the identification of discrepancies during the reconciliation process.

Step 2: Conduct Initial Data Review

Once you have prepared the necessary tools, it is critical to perform an initial review of the collected data. This review will serve as the foundation for the reconciliation process:

• Compare Source Data with EDC Entries: Review the source documents side-by-side with EDC entries to identify any discrepancies.
• Assess Dates and Times: Accurate dates and times ensure that events are chronologically aligned in both source documentation and EDC.
• Check Event Classifications: Ensure that AEs and SAEs are classified consistently across documents.

Step 3: Document the Findings

A critical part of any reconciliation process is thorough documentation. As discrepancies are noted, ensure that findings are documented clearly:

• Tracking Discrepancies: Create a log for all discrepancies identified, including a description, date discovered, and the individual responsible for resolution.
• Recording Resolutions: Identify how and when discrepancies will be addressed and document the corrective actions taken.

Step 4: Resolve Discrepancies

This phase requires collaboration between clinical teams to resolve discrepancies identified during earlier steps. Key actions to take include:

• Communicate with Sites: Engage investigators or site coordinators to clarify discrepancies directly from the source.
• Amend EDC Data as Needed: Make adjustments within the EDC system based on discussions and approved documentation.

Step 5: Final Review and Audit

The final step in the reconciliation process is a thorough audit of the updated records to ensure all corrections have been adequately executed:

• Perform a Quality Check: Verify that all required updates have been finalized and recorded.
• Audit Trail Review: Ensure that an audit trail exists for all changes made to the data in the EDC, documenting each adjustment appropriately.

Best Practices for Efficient Safety Reconciliation

Implementing best practices can enhance the efficiency of your safety reconciliation process. Some actionable recommendations include:

• Utilize Automation Tools: Leverage software solutions designed to streamline the reconciliation process, enabling quicker identification of discrepancies.
• Standardize Procedures: Develop internal standard procedures (SOPs) for safety reconciliation to foster consistency in processes across trials and studies.
• Training Staff: Regularly train staff involved in safety reconciliation on current compliance requirements and best practices.

Real-World Applications and Case Studies

In practice, examples of effective safety reconciliation can be seen across a variety of clinical trials, including >sanofi clinical trials> and newer interventions like the donanemab clinical trial. Each of these studies emphasizes the importance of rigorous safety monitoring procedures to ensure data integrity and patient safety. Analyzing past trials can provide valuable insights into potential pitfalls and successful strategies for improving safety reconciliation.

Conclusion

Safety reconciliation between EDC systems and source documents is a critical process for clinical research organization companies that ensures adherence to compliance regulations and promotes data integrity. By following a structured step-by-step process outlined in this guide, sponsors and CROs can optimize their safety reconciliation efforts, thereby enhancing the quality of clinical trial outcomes.

As the field of clinical research continues to evolve, remaining proactive in refining reconciliation processes will position organizations for success in future trials.